---
layout: template1
title: Dissemination
---

# Knowledge dissemination

## Contents
- [UB-Hospital Clinic Chair on Lung Cancer AstraZeneca](#UB-Hospital-Clinic-Chair-on-Lung-Cancer-AstraZeneca)
- [Networking](#networking)



## UB-Hospital Clinic Chair on Lung Cancer AstraZeneca

To create synergies to promote, share and disseminate the knowledge on the development, diagnosis, and treatment for lung cancer, our group have established a collaboration with the pharmaceutical company AstraZeneca to create the **UB-Hospital Clinic Chair on Lung Cancer AstraZeneca**.

**Chair Members:** 
Dr. Mariano Monzó (Director), Dr. Noemí Reguart, Dr. Alfons Navarro, Dr. Laureano Molins, Dr. Ramón M. Marrades, Dr. José Ramírez; and from Astrazeneca Company: Dr. Miquel Romans and Dr.Jordi Castignani.


![Foto Catedra]({{site.base.url}}/lab/assets/img/Catedra_pulmo.png){:height="50%" width="50%"}


**Testimonials:**

*“We are proud of being participants in its creation and glad to contribute to the knowledge transfer in order to make progresses in the treatment of lung cancer as well as to improve the life of patients. We believe continuous training of health professionals is essential in order to keep improving oncological assistance, and given the impact of the illness, we are glad to be part of this project together with the University of Barcelona and Hospital Clínic”.* - **Guillem Bruch, head of Oncology at Astrazeneca Spain**

*“...it is necessary to make advances in the dissemination and transfer of this knowledge to reach a better training for our students and professionals in the health field, as well as to provide our patients and families with better information through social actions such as the ones this new chair will carry out”.* - **Dr. Mariano Monzó, Chair director**


**Published News in relation to the Lung Cancer Chair:**

- [Hospital Clínic of Barcelona  new's: "The UB, Hospital Clínic and AstraZeneca create a knowledge transfer chair on lung cancer" - 11th February 2021](https://www.clinicbarcelona.org/en/news/the-ub-hospital-clinic-and-astrazeneca-create-a-knowledge-transfer-chair-on-lung-cancer)

- [Astrazeneca new's: "La UB, el Clínic y AstraZeneca crean una cátedra de transferencia de conocimiento en cáncer de pulmón" - 11th February 2021](https://www.astrazeneca.es/medios/notas-prensa/2021/la_ub_el_clinic_y_astrazeneca_crean_una_catedra_de_transferencia_de_conocimiento_en_cancer_de_pulmon.html#!)


- [Youtube video on Institutional inauguration ceremony](https://www.youtube.com/watch?v=q-Hqap5nK-8)

- [El Médico interactivo mew's: "Nueva cátedra de transferencia de conocimientos en cáncer de pulmón"](https://elmedicointeractivo.com/nueva-catedra-de-transferencia-de-conocimientos-en-cancer-de-pulmon/)


# Networking

### Member of the IDIBAPS group Inflamation and Repair in Respiratory diseases

The [Inflamation and Repair in Respiratory diseases group](https://www.clinicbarcelona.org/en/idibaps/areas-and-programs/respiratory-cardiovascular-and-renal-pathobiology-and-bioengineering/inflammation-and-repair-in-respiratory-diseases) is involved in the study of lung development and ageing as key pathogenic determinants of adulthood respiratory diseases and Early lung cancer diagnosis and prognosis. 

![Logo IDIBAPS]({{site.base.url}}/lab/assets/img/logos/Logotip_IDIBAPS.jpg){:height="15%" width="15%"}

### Member of the Thoracic Oncology unit of Hospital Clínic of Barcelona


[The Thoracic Oncology Unit](https://www.clinicbarcelona.org/unidad/tumores-toracicos) is made up of a team of professionals committed to the care of patients with lung cancer and other thoracic tumors. The objective is to achieve a clinical practice of excellence and guarantee the best quality care for patients.

![Logo Clinic]({{site.base.url}}/lab/assets/img/logos/Logotip_clinic.png){:height="15%" width="15%"}


The Unit includes six transversal axes focused on diagnosis, treatment, clinical research, translational research and teaching in lung cancer and other thoracic tumors.

The thirty components of the Unit are structured in fifteen core cores, defined by three main working groups: operational, support and research. The Operational Group is made up of all the members and services that participate daily in the diagnosis and therapeutic decision making and constitute the Thoracic Tumor Committee. The support and research groups include other healthcare professionals associated with the pathology, as well as *basic and translational research groups linked to the University of Barcelona* and the August Pi i Sunyer Biomedical Research Institute (IDIBAPS).
